AI in Healthcare and Life Sciences Podcast
Emerj Technology Research
0
The AI in Healthcare and Life Sciences Podcast is for non-technical leaders interested in where AI is creating an impact for patients, business workflows, and the bottom line. Global Fortune 500 healthcare and life sciences leaders join the Emerj AI Research team and CEO Daniel Faggella to share where they're seeing AI impact today, as well as best-practices for AI adoption and ROI measurement in healthcare and pharma.
Episodes
-
How AI Is Transforming Clinical Development and Real-World Evidence - with Nabil Khan of Pfizer 05.11.2026 21mClinical trials are designed to answer narrow scientific questions under controlled conditions, leaving clinicians to work out how strong evidence applies to the more diverse patients they actually treat. In this episode, Nabil Khan, Medical Director for Internal Medicine Antivirals at Pfizer, examines where evidence gets lost as data moves between trial sites, monitors, and sponsors, and how AI can help narrow that gap without replacing clinical judgment. He also outlines the foundations leaders need first: high-quality data, physician trust and engagement, regulatory alignment from the start... -
AI and Customer Experience in Behavioral Health - with Dwayne Stevens of WestCare 01.10.2026 26mAdministrative documentation is consuming thousands of clinician hours a year in behavioral health, pushing burnout higher and pulling staff away from direct patient care. In this episode, Dwayne Stevens, Chief Information Officer at Westcare Foundation, examines how AI-assisted documentation built into his organization's internally developed electronic health record is returning time to clinicians without removing their judgment from the record. The conversation covers his organization's Spirit and Touch frameworks for governed AI adoption, the cross-functional roles that drove implementation... -
What Service Leaders Get Wrong When Building the AI Business Case - with Ryan Makely of Bruker 03.09.2026 28mField service leaders in medical devices are under pressure to translate operational wins like first-time fix rates into hard financial outcomes their CFOs will fund. In this episode, Ryan Makely, Senior Director, CALID Service at Bruker, examines why conventional service metrics often fail to connect to profit and loss, and how leaders can build a financial case for AI-driven service investment. The conversation covers parts consumption and cost-per-case as low-hanging fruit for hard cost savings, and how aligning business unit goals with company-wide financial objectives helps secure funding... -
How AI Is Closing the Knowledge Gap in MedTech Field Service - with Mohit Sheera of Terumo Blood and Cell Technologies 06.08.2026 24mField service leaders in MedTech are facing a widening gap between rising equipment complexity and the technician expertise, data, and parts logistics needed to keep devices running. In this episode, Mohit Sheera, Strategic Planning Leader at Terumo Blood and Cell Technologies, examines how AI-enabled remote diagnostics and multimodal data synthesis are changing who can resolve a service issue and how quickly. The conversation covers technician knowledge gaps, fragmented service data, first-time-fix pressure, parts availability, and how leaders can sequence organizational change so AI-enabled... -
Closing the Decision‑Making Gap in Healthcare AI - with Raman Kaur of Elsevier 04.06.2026 25mFragmented data environments continue to slow clinical and operational decision‑making, even as AI adoption accelerates across healthcare. In this episode, Raman Kaur, Vice President of Technology at Elsevier, examines how leaders can close the gap between information and action with host Yolandi De Weerdt, focusing on context, shared definitions, and workflow‑aligned AI. She highlights the practical shifts required to simplify data foundations, reduce cognitive burden, and move from systems of record to systems of intelligence. Learn how consultants are winning business with evidence-based AI... -
Rethink Healthcare Workforce Strain with Data Enablement - with Tony Pastorino of Resultant 07.05.2026 31mClinician burnout takes hold long before most healthcare leaders see it, and the signals that could forecast it are often already being collected, but locked inside systems and teams that don't communicate. In this episode, Tony Pastorino, Director of Healthcare Strategy at Resultant, examines how a shift from data governance to what he calls "data enablement", paired with predictive analytics and direct conversations with frontline staff, allows leaders to address workforce strain before it reaches clinicians. The conversation covers the operational blind spots that obscure early workload sig... -
Driving the Transformation of Drug Discovery Through AI‑Ready Data Foundations - with Barry Bunin of CDD 13.04.2026 28mPersistent friction between experimental, computational, chemistry, and biology teams continues to slow discovery work, largely due to siloed data and tools that are too difficult for scientists to adopt. In this episode, Barry Bunin, CEO & President at Collaborative Drug Discovery, examines how simplifying data capture and creating a shared source of truth enables faster iteration, clearer model‑experiment alignment, and more effective collaboration across disciplines. The discussion highlights how accessible systems, real‑time visibility, and cross‑functional coordination allow organizations... -
AI That Clinicians Can Trust: Building Reliable Clinical Decision Support with Rhett Alden of Elsevier 02.04.2026 24mClinicians face a significant trust gap and administrative burden that hinders the effective deployment of AI at the point of care. In this episode, Rhett Alden, CTO at Elsevier, outlines how integrating transparent, peer-reviewed AI assistants directly into clinical workflows can mitigate physician burnout and reduce medical errors. The discussion examines the governance frameworks, data transparency requirements, and specialized training necessary to shift from skeptical experimentation to scalable, high-impact clinical adoption. Learn how brands work with Emerj and other Emerj Media options... -
Automated ECOAs That Reduce Risk and Improve Data Quality with Elan Josielewski & Anthony Mikulaschek of IQVIA 05.03.2026 28mClinical trials often slow down at the exact points where precision is most critical — manual coding steps, fragmented workflows, and regulatory processes that introduce avoidable risk. In this episode, Elan Josielewski, Senior Director of Patient Centered Solutions at IQVIA, and Tony Mikulaschek, Vice President of eCOA at IQVIA, discuss how connected automation removes these failure points across the ECOA lifecycle. They outline how pre‑validated digital instrument libraries replace months of manual coding with audit‑ready configurations, how automated documentation now covers more than 70% o... -
AI-Native Discovery in Pharma - with Alister Campbell of Dotmatics 05.02.2026 26mToday's guest is Alister Campbell, Vice President, Global Head of Science and Technology at Dotmatics. Campbell works at the intersection of scientific R&D, data strategy, and applied AI across the drug discovery lifecycle. Alister joins Emerj Client Narrative & Content Strategy Lead Nick Gertsch to discuss how data and AI are shifting pharma R&D from linear, empirical workflows toward tighter, more predictive discovery loops where experiments, simulation, and modeling inform decisions earlier and faster. If you've enjoyed or benefited from some of the insights of this episode, consider leavin... -
Leading Bold Change and Human-Centered Innovation in Healthcare - with Dr. Imamu Tomlinson of Vituity 01.01.2026 22mToday's guest is Dr. Imamu Tomlinson, CEO of Vituity and President of the Vituity Cares Foundation. Vituity is a physician-owned multispecialty partnership with 6,000+ clinicians across 690 locations. Dr. Tomlinson joins Emerj Editorial Director Marilie Fouché to unpack leadership for driving AI-enabled innovation in healthcare's slow ecosystem. Dr. Tomlinson also shares practical takeaways like channeling "disagreeableness" into questions, celebrating early data wins for buy-in, and using AI to offload transactional tasks — freeing time for empathy and human-centered decisions across 13 milli... -
Reducing Audit Friction and Driving Accountability with AI in Healthcare – with Yasemin Agatan of AdaptHealth 04.12.2025 29mToday's guest is Yasemin Agatan, Senior Vice President of Internal Audit at AdaptHealth, a provider of home medical equipment, supplies, and related services supporting patients living at home. Yasemin brings extensive experience in audit, compliance, and operational risk management within the healthcare sector. She joins Emerj Editorial Director Matthew DeMello to discuss how enterprise leaders can leverage data and AI to improve audit workflows, enhance transparency, and manage risk more effectively. Yasemin also highlights practical approaches for organizations, including improving data vis... -
Driving AI from Pilots to Business Impact in Pharma – with Alyssa Fenoglio of Teva Pharmaceuticals 06.11.2025 24mToday's guest is Alyssa Fenoglio, VP, Global Head of Digital Commercial at Teva Pharmaceuticals. Teva is a global pharmaceutical company delivering both generic and specialty medicines across more than 60 countries. Alyssa joins Emerj CEO and Head of Research Daniel Faggella to discuss the unique challenges of digital transformation in life sciences and how organizations can leverage data and AI to create real business impact. She also shares practical strategies for securing leadership support, linking AI pilots to measurable business outcomes, and building cross-functional teams to drive inn... -
Driving Audit Workflows in the Era of Agentic AI and IoT for Healthcare - with Yasemin Agatan of Adapt Health 02.10.2025 23mInternal audit sits at the crossroads of regulation, data, and business outcomes—nowhere more than in healthcare and medical devices. Yasemin Agatan, Sr. Vice President of Internal Audit at AdaptHealth, joins Emerj Editorial Director Matthew DeMello to unpack what an "AI-ready" audit looks like in one of the most complex and regulated environments. Yasemin lays out today's top pressures: rapidly shifting FDA and HIPAA requirements, thorny revenue recognition and reimbursement models, multi-party contracts, and a deluge of device and platform data. She then maps where AI is already moving the n... -
Dangers of Unchecked AI Development When Politics Meets Machine Learning - with John-Clark Levin of the Yorktown Institute 04.09.2025 59mIn this episode of the AI in Healthcare and Life Sciences podcast, host Matthew DeMello speaks with John-Clark Levin, Fellow at the Yorktown Institute and researcher at Kurzweil Research, about the intersection of U.S. politics, AI development, and biosecurity. Levin outlines why the coming years may prove decisive for artificial general intelligence (AGI) and how political volatility under the current administration could directly impact AI safety and regulation. He explains the unique risks of authoritarian tendencies in shaping AI policy, particularly when it comes to epistemics—how governm... -
Bridging the AI Trust Gap in Life Sciences Workflows - with John-Clark Levin of Kurzweil Technologies 07.08.2025 35mToday's guest is John-Clark Levin, Research Lead at Kurzweil Technologies. Kurzweil Technologies, Inc. (KTI) is a research and development company developing and marketing technologies in pattern recognition and artificial intelligence. In this episode, John-Clark unpacks the challenges of deploying AI in healthcare, focusing on reliability, risk tolerance, and the gap between model performance and real-world trust. He explores why even small error rates can derail adoption in high-stakes settings and how legal, institutional, and educational barriers often slow progress more than the technolo... -
Human-Centered AI and the Path to Transformation - with Francesco Tisiot of Aiven 03.07.2025 18mToday's guest is Francesco Tisiot, Field CTO at Aiven. Aiven provides fully managed, open-source data infrastructure on all major clouds. Their platform enables organizations to scale quickly, securely, and cost-effectively — freeing teams to focus on delivering AI applications and business outcomes. Francesco returns to the program to share a pragmatic perspective on AI adoption in highly regulated industries. He outlines how generative AI can eliminate repetitive tasks, accelerate decision-making, and improve employee engagement — without compromising trust or compliance. From co-pilot inter... -
Adopting AI Safely and Effectively in Life Sciences - with Francesco Tisiot of Aiven 05.06.2025 22mToday's guest is Francesco Tisiot, Field CTO at Aiven. Aiven provides fully managed, open-source data infrastructure on all major clouds. Their platform enables organizations to scale quickly, securely, and cost-effectively—freeing teams to focus on delivering AI applications and business outcomes. Francesco joins Emerj Senior Editor Matthew DeMello on today's show to discuss what it takes to responsibly adopt AI in highly regulated sectors like life sciences. Francesco shares insights from working across verticals and explains why starting with a clear understanding of data boundaries is more... -
The Role of AI in Educating the Next Generation of Healthcare Professionals - with Rhett Alden of Elsevier 01.05.2025 18mToday's guest is Rhett Alden, Chief Technology Officer at Elsevier. Elsevier is a global leader in information analytics and academic publishing, providing trusted scientific, technical, and medical content for researchers, clinicians, and professionals. Rhett returns to the podcast to explore how AI is reshaping healthcare education by bridging the gap between emerging technologies and traditional training methods. In this episode, Rhett shares how Elsevier is applying generative AI to enhance procedural training for healthcare students and professionals while emphasizing the continued import... -
Solving AI Transparency Challenges in Healthcare Data - with Rhett Alden of Elsevier 03.04.2025 22mToday's guest is Rhett Alden, Chief Technology Officer at Elsevier. Elsevier is a global leader in information analytics and academic publishing, providing trusted scientific, technical, and medical content for researchers, clinicians, and professionals. Rhett joins us on today's show to discuss how Elsevier is tackling hallucinations in AI frameworks to deliver reliable, peer-reviewed medical and scientific information. Alden explains how retrieval-augmented generation (RAG) models differ from large language models (LLMs), ensuring that AI-generated responses are grounded in verifiable, high-...
Popular in
The podcast also appears in the podcast charts of these countries.